Scientists at the University of Sheffield are launching a pioneering investigation to discover how diabetes affects heart and brain function in order to help the soaring number of people living with the disease.
University of Copenhagen chemist Jørn Bolstad Christensen has been tasked, as part of an International team, with developing a unique approach to attacking the deadly arterial deposits.
Patients suffering from high blood pressure - the single most important risk for death worldwide - could be helped by a UK-wide clinical trial aimed at improving treatments.
A research programme that will lay the foundations for anyone with cancer to have access to genetic testing has been launched with £2.7 million funding from the Wellcome Trust.
University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.
BioEquity is the top European event for life science investors showcasing companies on the forefront of innovation.
A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world.
Having too much body fat makes arteries become stiff after middle age, a new study has revealed.
Researchers at Queen’s University Belfast have devised a ‘magic bullet’ nanomedicine which could become the first effective treatment for Acute Lung Injury or ALI, a condition affecting 20 per cent of all patients in intensive care.
Scientists at the University of Southampton have begun a new study to evaluate the benefits of exercises and strategies for preventing falls among people with Parkinson’s disease.
New international study identifies questions on isolation, social stigma, impact on activities and feelings of hopelessness to help people with psoriasis
Cizzle Biotech secures partnership with Fujirebio Diagnostics Incorporated to develop lung cancer test
Cobra Biologics Ltd announces an agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.